Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Alhabib, Khalid F.1 (AUTHOR) ; Gamra, Habib2 (AUTHOR); Almahmeed, Wael3 (AUTHOR); Hammoudeh, Ayman4 (AUTHOR); Benkheddah, Salim5 (AUTHOR); Al Jarallah, Mohammad6 (AUTHOR); Al-Motarreb, Ahmed7 (AUTHOR); Alquraishi, Mothanna8 (AUTHOR); Sobhy, Mohamed9 (AUTHOR); Yousif, Magdi G.10 (AUTHOR); Alkindi, Fahad11 (AUTHOR); Fellat, Nadia12 (AUTHOR); Amin, Mohammad I.13 (AUTHOR); Ali, Muhammad14 (AUTHOR); Al Saleh, Ayman1 (AUTHOR); Ullah, Anhar1 (AUTHOR); Zannad, Faiez15 (AUTHOR)
- المصدر:
PLoS ONE. 7/22/2020, Vol. 15 Issue 7, p1-16. 16p.
- الموضوع:
- معلومة اضافية
- الموضوع:
- نبذة مختصرة :
Background: This pilot study describes the overall design and results of the Program for the Evaluation and Management of the Cardiac Events registry for the Middle East and North Africa (MENA) Region. Methods: This prospective, multi-center, multi-country study included patients hospitalized with acute myocardial infarction (AMI) and/or acute heart failure (AHF). We evaluated the clinical characteristics, socioeconomic and educational levels, management, in-hospital outcomes, and 30-day mortality rate of patients that were admitted to one tertiary-care center in each of 14 Arab countries in the MENA region. Results: Between 22 April and 28 August 2018, 543 AMI and 381AHF patients were enrolled from 14 Arab countries (mean age, 57±12 years, 82.5% men). Over half of the patients in both study groups had low incomes with limited health care coverage, and limited education. Nearly half of the cohort had a history of diabetes mellitus, hypertension, or hypercholesterolemia. Among patients with ST-elevation myocardial infarctions, 56.4% received primary percutaneous interventions, 24% received thrombolysis, and 19.5% received no acute reperfusion therapy. The main causes of AHF were ischemic heart diseases (55%) and primary valvular heart diseases (15%). The in-hospital and 30-day mortality rates were 2.0% and 3.5%, respectively, for AMI, and 5.4% and 7.0%, respectively, for AHF. Conclusions: This pilot study revealed a high prevalence of cardiovascular risk factors in patients with AMI and AHF in Arab countries, and low levels of socioeconomic and educational status. Future phases of the study will improve our understanding of the impact that these factors have on the management and outcomes of cardiac events in these patient populations. [ABSTRACT FROM AUTHOR]
No Comments.